Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/1998
04/28/1998US5744452 Immune system disorders, aids
04/28/1998US5744451 N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity
04/28/1998US5744362 Antisense oligonucleotide modulation of raf gene expression
04/28/1998US5744339 Thiomethylene group-containing aldehyde cysteine and serine protease inhibitors
04/28/1998US5744316 Used to identify individuals diagnosed with conditions characterized by cellular abnormalities
04/28/1998US5744168 Administering to a human or animal a bismuth compound and one or more microbiocides
04/28/1998US5744167 Topically administering stannous halide or mixture of stannous halides
04/28/1998US5744165 Antiinflammatory agents, analgesics
04/28/1998US5744164 Sustained release microparticulate caffeine formulation
04/28/1998US5744157 Preparation for maintaining and/or increasing muscular power and body cell mass
04/28/1998US5744156 Use of a substance P antagonist for the treatment of skin reddening of neurogenic origin
04/28/1998US5744154 Includes cyclodextrin etherified with c 1-4 alkyl or c 1-4 hydroxyalkyl groups
04/28/1998US5744143 Viral vaccines
04/28/1998US5744138 Process for separating organogermanium compounds and inorganogermanium compounds from a germanium-containing pharmaceutical plant or its processed products
04/28/1998US5744127 Sunscreens in cosmetics and stabilization of synthetic polymers
04/28/1998US5744125 Oxidative polymerization of precursors that enhance substantivity or adherence to hair or skin
04/28/1998US5744124 Container having pump spray means for dispensing spray dosage into buccal area; propellant-free
04/28/1998US5744123 Aerosol formulations containing P134a and particulate medicaments
04/28/1998CA2203621C Use of hyaluronic acid for the treatment of interstitial cystitis
04/28/1998CA2118937C Triazole antifungal agents
04/28/1998CA2077653C Phenyl butyl nitrone compositions for prevention of gastric ulceration
04/28/1998CA2076650C Roquinimex for treating hiv infections
04/28/1998CA2060474C Pharmaceutical use
04/28/1998CA2056906C Use of phenylethanolaminotetralins for the preparation of anti-depressant and anti-stress pharmaceutical compositions
04/28/1998CA2030108C Process for the preparation of genetic vectors for the expression of nerve growth factor in eukaryotic cells
04/28/1998CA2027053C Estrogen-containing active substance plaster
04/28/1998CA2021923C Pharmaceutical composition containing hydantoin derivative
04/28/1998CA2013050C Transdermal therapeutic system exhibiting an increased active substance flow and process for the production thereof
04/25/1998CA2218756A1 Substituted benzo¢b!thiophene compounds having activity as selective estrogen receptor modulators
04/24/1998CA2215647A1 Naphthyl compounds, compositions, and methods
04/23/1998WO1998016918A1 Method for recovering data from disk with magneto-resistive head in presence of thermal asperities
04/23/1998WO1998016834A1 Diagnosis of spongiform encephalopathy
04/23/1998WO1998016559A1 Cervical canal maturing agent
04/23/1998WO1998016544A1 8(9)-dehydroestradiol derivatives
04/23/1998WO1998016543A1 Remedy for chronic fatigue syndrome
04/23/1998WO1998016532A1 Triterpene derivatives with immunosuppressant activity
04/23/1998WO1998016531A1 Triterpene derivatives with immunosupressant activity
04/23/1998WO1998016530A1 AZAHETEROCYCLYMETHYL DERIVATIVES OF 2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO[2,3-e]INDOL-8-ONE
04/23/1998WO1998016527A1 Benzoxepine derivatives which promote release of growth hormone
04/23/1998WO1998016521A1 Aminothiophene carboxylic acid amides and the use thereof as phosphodiesterase inhibitors
04/23/1998WO1998016520A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
04/23/1998WO1998016518A1 Triterpene derivatives with immunosuppressant activity
04/23/1998WO1998016515A1 Compounds and methods to treat infectious diseases
04/23/1998WO1998016512A1 New derivates from piperidine-keto acid, their preparation and use
04/23/1998WO1998016509A1 Simple process for producing high-quality captopril
04/23/1998WO1998016507A2 New heterocyclylmethyl-substituted pyrazol derivates and their use for treating cardiovascular diseases
04/23/1998WO1998016506A1 Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors
04/23/1998WO1998016505A1 SULFONAMIDE INTERLEUKIN-1β CONVERTING ENZYME INHIBITORS
04/23/1998WO1998016504A2 SULFONAMIDE SUBSTITUTED ASPARTIC ACID INTERLEUKIN-1β CONVERTING ENZYME INHIBITORS
04/23/1998WO1998016503A2 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
04/23/1998WO1998016502A1 ASPARTATE ESTER INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
04/23/1998WO1998016266A1 Implantable acrylamide copolymer hydrogel for therapeutic uses
04/23/1998WO1998016251A1 New carrier systems
04/23/1998WO1998016250A1 Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity
04/23/1998WO1998016247A1 Immunostimulatory polynucleotide/immunomodulatory molecule conjugates
04/23/1998WO1998016239A1 CITRUS PEEL EXTRACT AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR
04/23/1998WO1998016237A1 Anion exchange resin-containing tablets
04/23/1998WO1998016236A1 Composition and method for treating fungal disease in animals
04/23/1998WO1998016235A1 Peripheral blood stem cell-increasing agents containing glycosides
04/23/1998WO1998016234A1 Long chain carboxybetaines in antimicrobial formulations
04/23/1998WO1998016233A1 Formulations containing phosphatidylethanolamine
04/23/1998WO1998016232A1 Use of 8,9-dehydroestrone for the manufacture of a medicament for the treatment of vasomotor symptoms
04/23/1998WO1998016231A1 Soporific containing lorazepam and diphenhydramine
04/23/1998WO1998016230A1 Methods for reversibly inhibiting myelopoiesis in mammalian tissue
04/23/1998WO1998016229A1 Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
04/23/1998WO1998016228A1 USE OF AN H+, K+-ATPase INHIBITOR IN THE TREATMENT OF NASAL POLYPS
04/23/1998WO1998016227A1 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
04/23/1998WO1998016226A1 Use of lofexidine in the treatment of behavioral disorders
04/23/1998WO1998016225A1 Treatment of urinary incontinence and compositions for use therein
04/23/1998WO1998016224A1 Pyrazolinones to treat disturbances of potency
04/23/1998WO1998016223A1 Use of condensated (hetaryl-substituted) 1-benzal-3-pyrazol derivates for treating special diseases of the cardiovascular and the central nervous systems
04/23/1998WO1998016222A1 Preparation of 3-fluoro oxindole derivatives
04/23/1998WO1998016221A1 NARINGIN AND NARINGENIN AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR
04/23/1998WO1998016220A1 HESPERIDIN AND HESPERETIN AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR
04/23/1998WO1998016219A1 The medicine containing triptolide for preventing and/or treating acute graft rejection
04/23/1998WO1998016218A1 Use of metal complexes to treat gastrointestinal infections
04/23/1998WO1998016216A1 Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid
04/23/1998WO1998016215A1 Use of essential fatty acids for the treatment and prevention of radiation damage to erythrocytes
04/23/1998WO1998016214A1 Secondary cataract inhibitor
04/23/1998WO1998016213A1 Use of sodium 2-mercaptoethanesulfonate in surgery
04/23/1998WO1998016212A1 Local anesthetic for external use
04/23/1998WO1998016211A1 Method for the enhancement of lymphocyte activity against opportunistic microbial pathogens and tumors
04/23/1998WO1998016210A1 Fluorocarbon-containing agents for pulmonary lavage and drug delivery
04/23/1998WO1998016208A1 Methods and apparatus for treatment of parkinson's disease
04/23/1998WO1998016206A1 Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
04/23/1998WO1998016205A2 Stable glassy state powder formulations
04/23/1998WO1998016204A1 Process for the manufacture of a pulverous preparation
04/23/1998WO1998016201A1 Therapeutic liposome composition and method
04/23/1998WO1998016200A1 Carriers containing an etherlipid/complementarily shape lipid combination and therapeutic uses thereof
04/23/1998WO1998016195A1 Pharmaceutical formulation
04/23/1998WO1998016186A2 Monocyclic l-nucleosides, analogs and uses thereof
04/23/1998WO1998016184A2 Purine l-nucleosides, analogs and uses thereof
04/23/1998WO1998016111A1 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
04/23/1998WO1998016107A1 Method for the prevention of the reinfestation of warm-blooded animals by ectoparasites
04/23/1998WO1998016104A1 Antimicrobial lipids
04/23/1998WO1998011101A3 Condensed n-aclyindoles as antitumor agents
04/23/1998WO1998009170A3 Methods and compositions for the detection of cervical cancer
04/23/1998WO1998008546A3 Therapeutic combinations of rar antagonists and rxr agonists and use thereof
04/23/1998WO1998007429A3 Antifungal composition with enhanced bioavailability
04/23/1998WO1998005308A3 Terazosin capsules
1 ... 6663 6664 6665 6666 6667 6668 6669 6670 6671 6672 6673 6674 6675 6676 6677 6678 6679 6680 6681 6682 6683 ... 7860